LianBio (LIAN): Hmmm bunch of buy volume this morning

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Reply Private New

Keep Last Read

Prev Next

Send PM Follow Ignore

Followers	186
Posts	13737
Boards Moderated	0
Alias Born	08/26/2010

Re: None

Friday, 03/15/2024 8:55:26 AM

Friday, March 15, 2024 8:55:26 AM

Hmmm bunch of buy volume this morning

Keep Last Read

Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent LIAN News

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 03/11/2024 11:51:34 AM
LianBio Announces Voluntarily Delisting from Nasdaq • GlobeNewswire Inc. • 02/28/2024 12:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:10:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 12:04:28 PM
LianBio Announces Completion of Strategic Review • GlobeNewswire Inc. • 02/13/2024 12:00:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/08/2024 11:13:42 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/29/2023 12:56:48 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 09:10:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:07:12 PM
Biotech Finds Success Following Holiday Weekend • AllPennyStocks.com • 12/26/2023 07:40:00 PM
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets • GlobeNewswire Inc. • 12/26/2023 07:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:05:09 PM
LianBio Announces Departure of Chief Financial Officer • GlobeNewswire Inc. • 12/20/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:26:35 PM
LianBio Announces Departure of Chief Executive Officer • GlobeNewswire Inc. • 12/19/2023 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:23:14 PM
LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences • GlobeNewswire Inc. • 12/06/2023 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:16:07 PM
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences • GlobeNewswire Inc. • 12/01/2023 09:05:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:28:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:17:38 PM
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:16:40 PM
LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis • GlobeNewswire Inc. • 10/30/2023 08:05:00 PM
LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023 • GlobeNewswire Inc. • 10/25/2023 08:05:00 PM

More LIAN News

InvestorsHub NewsWire

FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow